Evidence map›Paper›PMID 34309986›Full record

ArticleEuropean journal of neurology2021

Multinational descriptive analysis of the real-world burden of headache using the Migraine Buddy application.

Peter J Goadsby, Luminita Constantin, Caty Ebel-Bitoun, Iva Igracki Turudic, Simon Hitier, Caroline Amand-Bourdon, Andrew Stewart

Open access · hybridAbstract read
In one paragraph

Article in European journal of neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Peter J GoadsbyNIHR-Wellcome Trust King's Clinical Research Facility, King's College London, London, UK.ORCID 0000-0003-3260-5904
Luminita ConstantinConsumer Healthcare, Sanofi, Gentilly, France.ORCID 0000-0002-1754-6478
Caty Ebel-BitounConsumer Healthcare, Sanofi, Gentilly, France.
Iva Igracki TurudicConsumer Healthcare, Sanofi, Frankfurt, Germany.
Simon HitierConsumer Healthcare, Sanofi, Gentilly, France.
Caroline Amand-BourdonReal World Evidence, Sanofi, Chilly-Mazarin, France.
Andrew StewartReal World Evidence, Sanofi, Boston, MA, USA.
Sanofi (France) · FRKing's College London · GBSanofi (Germany) · DESanofi (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeA large proportion of headache sufferers do not routinely seek medical care. App-based technologies permit the collection of real-world data over time and between countries that can help assess true burden of headache. This study used a mobile phone application to collect information on the real-world burden of self-diagnosed headache and to describe its impact on daily life in headache sufferers who do not routinely seek medical advice.

methodsThis retrospective, non-interventional, cross-sectional study analysed self-reported data from users of the 'Migraine Buddy' app. The main objective was to describe self-reported characteristics of headache and migraine (triggers, duration, frequency), treatment patterns and impact on daily activity in headache sufferers from Australia, Brazil, France, Germany and Japan. Data including demographics, self-diagnosed episode type (headache/migraine), duration, potential triggers and impact on daily activity are reported. All analyses were exploratory and performed per country.

resultsSelf-reported data were collected from 60,474 users between August 2016 and August 2018. Approximately 90% of users were females; >60% were aged 24-45 years. Over one-third of users reported having two to five episodes of headache or migraine per month; impact included impaired concentration, being slower and missing work or social activities. Variations across countries were observed; within countries, episode characteristics were very similar for self-diagnosed headache versus migraine.

conclusionsHeadache tracking was used to describe the experience, impact and self-management approaches of migraine and headache sufferers in a real-world setting. Headache disorders present a range of important issues for patients that deserve more study and reinforce the need for better approaches to management.

Indexed as

Migraine DisordersMobile ApplicationsAdultCross-Sectional StudiesFemaleHeadacheHumansMiddle AgedRetrospective StudiesYoung Adultheadacheheadache impactheadache triggersreal-world evidence

Identifiers

PMID34309986
PMCPMC9291858
OpenAlexW3184341584

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.